U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
167821167821Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne VulgarisCompletedNo Results AvailableAcne VulgarisDrug: clindamycin phosphate|Drug: salicylic acidhttps://ClinicalTrials.gov/show/NCT00361322
167822167822SU011248 in Advanced Hepatocellular CarcinomaCompletedNo Results AvailableHepatocellular Carcinoma|Liver CancerDrug: SU011248https://ClinicalTrials.gov/show/NCT00361309
167823167823Vaccine Therapy in Treating Patients With Myelodysplastic SyndromesActive, not recruitingNo Results AvailableMyelodysplastic SyndromesBiological: GM-K562 cell vaccinehttps://ClinicalTrials.gov/show/NCT00361296
167824167824Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early AtherosclerosisCompletedHas ResultsInflammationDrug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT00361283
167825167825Treatment of Veterans With Chronic Low Back PainActive, not recruitingHas ResultsLow Back Pain, RecurrentBehavioral: BIO|Behavioral: Hyp-2 w recordings|Behavioral: Hyp-8|Behavioral: Hyp-8 w recordingshttps://ClinicalTrials.gov/show/NCT00361270
167826167826Minocycline for the Treatment of Decreased Mental Function in HIV-Infected AdultsTerminatedHas ResultsHIV InfectionsDrug: Minocycline|Drug: Placebo (Tetracycline)https://ClinicalTrials.gov/show/NCT00361257
167827167827SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerActive, not recruitingNo Results AvailableColorectal CarcinomaDrug: SU011248|Drug: Irinotecan|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00361244
167828167828Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompletedNo Results AvailableBiliary Tract Cancer|Gallbladder AdenocarcinomaDrug: Bevacizumab|Drug: Gemcitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00361231
167829167829Biological Markers of Response to Treatment in Major Depressive DisorderCompletedHas ResultsMajor Depressive DisorderDrug: open-label selective serotonin reuptake inhibitor (SSRI)https://ClinicalTrials.gov/show/NCT00361218
167830167830Electronic Compliance Monitoring in Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDevice: Electronic Monitoring caphttps://ClinicalTrials.gov/show/NCT00361205
167831167831Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal ArteritisRecruitingNo Results AvailableTemporal Arteritis|Duplex of Temporal Artery|Biopsy of Temporal ArteryProcedure: biopsy of temporal arteryhttps://ClinicalTrials.gov/show/NCT00361192
167832167832Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNo Results AvailableCoinfection With Hepatitis B Virus and Hepatitis C Virus|Monoinfection With Hepatitis C Virushttps://ClinicalTrials.gov/show/NCT00361179
167833167833Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and RisperidoneCompletedNo Results AvailableSchizophreniaDrug: ACP-103https://ClinicalTrials.gov/show/NCT00361166
167834167834Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Colesevelam hydrochloride|Drug: placebohttps://ClinicalTrials.gov/show/NCT00361153
167835167835Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)CompletedHas ResultsMyelodysplastic Syndromes|Myeloproliferative Disorders|Leukemia, Lymphocytic|Myeloma|LymphomaDrug: Busulfan|Drug: Fludarabinehttps://ClinicalTrials.gov/show/NCT00361140
167836167836Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart FailureRecruitingNo Results AvailableHeart Failure, CongestiveDrug: isotonic saline infusionhttps://ClinicalTrials.gov/show/NCT00361127
167837167837IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.TerminatedNo Results AvailableMalariaDrug: sulphadoxine/pyrimethamine|Drug: Chlorproguanil/dapsone|Drug: Sulfadoxine/pyrimethaminehttps://ClinicalTrials.gov/show/NCT00361114
167838167838A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic VirusCompletedNo Results AvailableHIV Infections|X4 Tropic VirusDrug: AMD11070https://ClinicalTrials.gov/show/NCT00361101
167839167839A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: PS-341|Drug: R11577https://ClinicalTrials.gov/show/NCT00361088
167840167840Midlife Cholesterol StudyCompletedNo Results AvailableMenopause|Postmenopause|Premenopause|Cardiovascular DiseaseDrug: transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium)https://ClinicalTrials.gov/show/NCT00361075
167841167841Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of TreatmentRecruitingNo Results AvailableAdverse Effects|AggressionBehavioral: comparative computer simulationhttps://ClinicalTrials.gov/show/NCT00361062
167842167842Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantCompletedNo Results AvailableCancerBiological: graft versus host disease prophylaxis/therapy|Genetic: fluorescence in situ hybridization|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: in vitro-treated bone marrow transplantation|Procedure: management of therapy complicationshttps://ClinicalTrials.gov/show/NCT00361049
167843167843Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic AgentCompletedNo Results AvailableLeiomyoma|Leiomyomatosis|Uterine NeoplasmsDevice: Uterine fibroid embolization BeadBlock™|Device: Uterine fibroid embolization Embosphere®https://ClinicalTrials.gov/show/NCT00361036
167844167844Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and NephropathyCompletedNo Results AvailableType 2 Diabetes|Diabetic NephropathyDrug: losartanhttps://ClinicalTrials.gov/show/NCT00361023
167845167845A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence EpilepsyCompletedNo Results AvailableEpilepsy|Childhood Absence Epilepsy|SeizuresDrug: Levetiracetamhttps://ClinicalTrials.gov/show/NCT00361010
167846167846Investigation of Acceptable Dose of Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After StrokeRecruitingNo Results AvailableStrokeBehavioral: Conventional UK physical therapy (Con UK PT)|Behavioral: Con UK PT + 30 minutes/day Mobilisation & Tactile Stimulation (MTS)|Behavioral: Con UK PT + 60 minutes a day MTS|Behavioral: Con UK PT + 120 minutes a day MTShttps://ClinicalTrials.gov/show/NCT00360997
167847167847Prevention of Severe Hypoglycemia in Type 1 DiabetesCompletedNo Results AvailableType 1 Diabetes MellitusDrug: insulin glargine|Device: continuous subcutaneous insulin infusionhttps://ClinicalTrials.gov/show/NCT00360984
167848167848Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck CancerTerminatedHas ResultsHead and Neck Cancer|Mucositis|Pain|Radiation ToxicityBiological: palifermin|Drug: cisplatin|Other: placebo|Procedure: neck dissection|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00360971
167849167849Treatment of Severe Heart Failure by UltrafiltrationRecruitingNo Results AvailableSevere Congestive Heart FailureProcedure: ultrafiltrationhttps://ClinicalTrials.gov/show/NCT00360958
167850167850Cisplatin and Temozolomide in Treating Young Patients With Malignant GliomaActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: cisplatin|Drug: temozolomide|Genetic: fluorescence in situ hybridization|Genetic: loss of heterozygosity analysis|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00360945

* Görseller ve İçerik tekif hakkına sahip olabilir